CDEK
← All organizations
Millennium Pharmaceuticals

Millennium Pharmaceuticals

For profitContributed to NME

Also known as: Millenium Pharmaceuticals | Millennium Pharmaceuticals, Inc. | MILLENNIUM PHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2000

First marketed drug

May 7, 2001

First NDA

May 7, 2001

Last known activity

Jan 1, 2021

Acquired by Takeda on May 9, 2008

Timeline

1990s

  1. Jan 1, 1993

    Millennium Pharmaceuticals— Founded

  2. Oct 1, 1999

    Leukosite— Acquired

2000s

  1. Jul 1, 2000

    Cambridge Discovery Chemistry— Acquired

  2. May 7, 2001

    alemtuzumab— NDA Organization

  3. Dec 7, 2001

    COR Therapeutics— Acquired

  4. May 9, 2008

    Takeda— Acquired By

2010s

  1. Nov 20, 2015

    ixazomib— NDA Secondary Org

Drugs by trial phase (157 distinct, 401 trials)

Indications

Approved for

Studied for

Marketed drugs (3)

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Cambridge, MA, US Jan 1, 1993
First NDA
May 7, 2001
Last known activity
Jan 1, 2021

Designations held

  • Orphan drug
  • Fast track
  • Priority review
  • Accelerated approval

Notes

Acquired by Takeda